Your Article Summary
See Latest ArticlesSafety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers
Antimicrobial Agents and Chemotherapy, 07/01/09
Bitzan M et al. - The conclusion is that c(alpha)Stx1 and c(alpha)Stx2, given as individual or combined short intravenous infusions, are well tolerated. These results form the basis for future safety and efficacy trials with patients with STEC infections to ameliorate or prevent HUS and other complications.
Related Articles
Evaluation of Cynomolgus Monkey PXR, Primary Hepatocyte and In Vivo Pharmacokinetic Changes in Predicting Human CYP3A4 Induction
Drug Metabolism and Disposition, 10/21/09
Relevance Score: 89%
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects
British Journal of Clinical Pharmacology, 10/20/09
Relevance Score: 89%
Antiretroviral Adherence and Pharmacokinetics: Review of their Roles in Sustained Virologic Suppression
AIDS Patient Care and STDs, 10/05/09
Relevance Score: 89%
Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children
Acta Anaesthesiologica Scandinavica, 10/16/09
Relevance Score: 88%
Pharmacokinetic Outcomes of a Simplified, Weight-Based, Extended-Interval Gentamicin Dosing Protocol in Critically Ill Neonates
Pharmacotherapy, 10/27/09
Relevance Score: 87%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/16/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
The chemokine CXCL13 in acute neuroborreliosis
Journal of Neurology, Neurosurgery, and Psychiatry , 12/16/09
The immunobiology of viral arthritides
Pharmacology & Therapeutics, 12/16/09
Hepatic profile analyses of tipranavir in Phase II and III clinical trials
BMC Infectious Diseases, 12/16/09